Articles by J. Christopher Gallagher, MD

Advances in osteoporosis from 1970 to 2018

Gallagher, J. Christopher

Menopause. 25(12):1403-1417, December 2018.

Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials

Gallagher, J. Christopher; Palacios, Santiago; Ryan, Kelly A.; More

Menopause. 23(10):1083-1091, October 2016.

Bone mineral density measurements: how often should bone mineral density be measured in postmenopausal women? Results from the Women’s Health Initiative study

Gallagher, J. Christopher

Menopause. 22(6):581-583, June 2015.

Buy
Erratum

Estrogen treatment does not reduce fractures?

Gallagher, J. Christopher

Menopause. 21(2):111-112, February 2014.

Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms

Yalamanchili, Vinod; Gallagher, J. Christopher

Menopause. 19(6):697-703, June 2012.

Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization

Karim, Roksana; Dell, Richard M.; Greene, Denise F.; More

Menopause. 18(11):1172-1177, November 2011.

Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes

Sai, Adarsh J.; Gallagher, J. Christopher; Fang, Xiang

Menopause. 18(10):1101-1112, October 2011.

Effect of early menopause on bone mineral density and fractures

Gallagher, J. Christopher

Menopause. 14(3):567-571, May-June 2007.

The effect of soy protein isolate on bone metabolism

Gallagher, J. Christopher; Satpathy, Ruby; Rafferty, Karen; More

Menopause. 11(3):290-298, May-June 2004.

Secondary Logo

Journal Logo

Articles by J. Christopher Gallagher, MD

Advances in osteoporosis from 1970 to 2018

Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials

Bone mineral density measurements: how often should bone mineral density be measured in postmenopausal women? Results from the Women’s Health Initiative study

Estrogen treatment does not reduce fractures?

Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms

Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization

Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes

In Brief:

Effect of early menopause on bone mineral density and fractures

In Brief:

The effect of soy protein isolate on bone metabolism

In Brief:

More About This Author

Login

Register for a free account

In Brief:

In Brief:

In Brief: